Pluri Inc SEC Filings

Pluri Inc. reported that Chief Executive Officer and director Yaky Yanay received a grant of 6,588 restricted stock units of common stock on December 4, 2025, at a price of $0 per share under the company's 2019 Equity Compensation Plan.

The RSUs vest in equal installments on a monthly basis over three months following the grant date. After this award, Yanay beneficially owns 497,758 shares of common stock directly and 836 shares indirectly through Yaacov Yanay Management Ltd.

Pluri Inc. director Rami Avraham Levi reported a stock-based compensation grant on Form 4. On December 4, 2025, he acquired 653 shares of Pluri common stock as restricted stock units at a stated price of $0 per share under the company’s 2019 Equity Compensation Plan. Following this grant, he beneficially owned 18,967 shares of common stock in total. The RSUs were approved by the Board of Directors and are scheduled to vest in equal monthly installments over three months after the grant date, providing short-term, time-based equity incentives linked to continued service.

Pluri Inc. (PLUR) reported insider activity involving director and 10% owner Alexandre Weinstein and his entities Chutzpah Holdings Limited and Plantae Bioscience Ltd. On February 25, 2025, 10,250 common shares were acquired at a price of $0, held directly. On October 29, 2025, 1,002,169 pre-funded warrants with an exercise price of $0.0001 per share were exercised into common stock, resulting in 1,933,415 common shares indirectly held through Chutzpah.

Separately, on April 28, 2025, 452,702 common shares were purchased at $4.61 per share and are indirectly held through Plantae. The filing explains that Chutzpah and Plantae are controlled by Mr. Weinstein, who may be deemed to beneficially own their holdings, while formally disclaiming beneficial ownership beyond his pecuniary interest. It also notes that 84,599 common warrants related to a January 23, 2025 securities purchase agreement are exercisable until June 30, 2028.

Pluri Inc. (PLUR) reported a director’s equity award on a Form 4. On November 12, 2025, the director acquired 11,685 shares of common stock at $0, reflecting a grant of restricted stock units (RSUs) under the company’s 2019 Equity Compensation Plan. Following the transaction, the director beneficially owned 11,685 shares. The RSUs vest over three years: 50% vests ratably on a quarterly basis in the first year, then 25% in the second year and 25% in the third year.

Pluri Inc. reported that its Board granted CEO Yaky Yanay equity awards recognizing 2025 performance. The package includes 39,050 fully vested RSUs and stock options for 39,050 shares, exercisable for three years at an exercise price of $5.00 per share. The Board also approved a contingent award of 9,266 RSUs and options for 9,266 shares, with a grant date upon satisfaction of specified objectives by December 31, 2025, and the options exercisable for three years at $5.00.

Pluri Inc. (PLUR) CEO Yaky Yanay filed a Form 4 reporting equity awards on 10/15/2025. He acquired 39,050 restricted stock units at $0, which are fully vested, and 39,050 stock options with a $5 exercise price that are fully vested and expire on 10/15/2028.

Following these transactions, he beneficially owns 491,170 shares directly, plus 836 shares held indirectly through Yaacov Yanay Management Ltd. The filing lists his roles as Chief Executive Officer and Director and indicates it was filed by one reporting person.

Eitan Ajchenbaum, identified as a Director of Pluri Inc. (ticker PLUR), filed an initial Form 3 relating to an event on 09/10/2025. The filing states no securities are beneficially owned by the reporting person. The form was signed on 09/22/2025 and was filed by one reporting person.

Pluri Inc. filed a shelf registration/prospectus related to resale of 3,425,488 common shares by selling shareholders and discloses 8,155,948 shares outstanding as of September 16, 2025. The company will not receive proceeds from those resales, but could receive approximately $724,686 if outstanding warrants and pre-funded warrants are exercised for cash at exercise prices of $5.568 and $0.00001, respectively. The prospectus lists share-based instruments outstanding including stock options (weighted average exercise prices of $10.40 and $18.72 and others), 2,151,809 shares issuable upon exercise of warrants/pre-funded warrants at a weighted average exercise price of $4.27, and 564,564 shares issuable upon vesting of RS/RSUs. The Common Shares trade on Nasdaq under the symbol PLUR. The prospectus cautions that an investment is highly speculative and directs readers to the Risk Factors section.